Skip to main content

Table 3 Performance of ESLA-7 in multivariate setting when adjusted for age, stage and stratified for gender

From: A robust prognostic gene expression signature for early stage lung adenocarcinoma

Cohort

HR

CI

p

N

events

Lee et al. 2008 [4]

2.9

1.2–7.1

*

51

24

Zhu et al. 2010 [5]

4.9

1.3–18.1

*

32

14

Shedden et al. 2008 [6]

2.0

1.2–3.5

*

207

64

Rousseaux et al. 2013 [7]

2.6

1.2–5.8

*

84

31

Okayama et al. 2012 [8]

3.1

1.2–7.9

*

204

27

Botling et al. 2013 [9]

1.1

0.3–3.9

 

35

14

Der et al. 2014 [10]

3.2

1.6–6.2

***

127

44

  1. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us